Repurposing drug molecules for new pulmonary therapeutic interventions

Area of Science:

• Pulmonary Medicine
• Pharmacology
• Drug Discovery

Background:

• Drug repurposing accelerates the identification of novel molecules for pulmonary interventions.
• Existing therapies for lung diseases often face limitations, necessitating innovative approaches.
• Pulmonary diseases represent a significant global health burden, driving the need for effective treatments.

Purpose of the Study:

• To provide insights into drug repurposing strategies for effective pulmonary therapy.
• To highlight the advantages and potential of drug repurposing in treating lung diseases.
• To offer a comprehensive account of pulmonary drug repurposing.

Main Methods:

• Review of existing literature on drug repurposing and pulmonary diseases.
• Analysis of challenges including clinical trials, drug delivery, and regulatory issues.
• Inclusion of chemistry manufacturing and control (CMC) strategies.
• SWOT (Strengths, Weaknesses, Opportunities, Threats) analysis for pulmonary drug repurposing.

Main Results:

• Drug repurposing presents a viable strategy to overcome hurdles in developing new pulmonary interventions.
• Identified key challenges such as clinical trial design, drug delivery systems, and regulatory pathways.
• Highlighted the importance of CMC and human ergonomics in successful drug repurposing.
• SWOT analysis provides a framework for strategic development in pulmonary drug repurposing.

Conclusions:

• Drug repurposing offers a promising avenue for developing novel and effective treatments for pulmonary diseases.
• Addressing multifaceted challenges is crucial for the successful implementation of pulmonary drug repurposing.
• This review serves as an inclusive resource for researchers and clinicians in the field of pulmonary drug repurposing.